{"id":58112,"name":"SAVE RARE TREATMENTS TASK FORCE","slug":"save-rare-treatments-task-force","state":"DC","country":"United States of America","description":"Dedicated to restoring the spirit of R&D incentives in the Orphan Drug Act.","totalSpending":440000,"filings":10,"yearlySpending":[{"year":2023,"income":10000},{"year":2024,"income":220000},{"year":2025,"income":210000}],"issues":["HCR"],"firms":["LEAVITT PARTNERS, LLC"],"lobbyists":["ROBERT ALSPACH","JOSH TRENT","SHANNON DEERE","AMY RICK"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain excluded","Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain excluded","Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain excluded","Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain excluded","Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain excluded"],"years":[2023,2024,2025]}